Learn About Limb-Girdle Muscular Dystrophy Type 2C

What is the definition of Limb-Girdle Muscular Dystrophy Type 2C?
Limb-girdle muscular dystrophy type 2C (LGMD2C) is a genetic condition that affects the voluntary muscles around the hips and shoulders. This condition belongs to a group of muscle disorders called limb-girdle muscular dystrophies, which are characterized by progressive loss of muscle bulk and symmetrical weakening of voluntary muscles. Symptoms may additionally include: enlargement (hypertrophy) of the calf muscle and tongue, diseases of the heart muscle (cardiomyopathy), and respiratory abnormalities. LGMD2C is caused by genetic changes in the SGCG gene and is inherited in an autosomal recessive manner.
Save information for later
Sign Up
What are the alternative names for Limb-Girdle Muscular Dystrophy Type 2C?
  • Limb-girdle muscular dystrophy, type 2C
  • Adhalin deficiency, secondary
  • Autosomal recessive limb-girdle muscular dystrophy type 2C
  • DMDA
  • DMDA1
  • Duchenne-like muscular dystrophy, autosomal recessive, type 1
  • Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5
  • Gamma-sarcoglycan-related LGMD R5
  • Gamma-sarcoglycanopathy
  • LGMD due to gamma-sarcoglycan deficiency
  • LGMD type 2C
  • LGMD2C
  • Limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency
  • Limb-girdle muscular dystrophy type 2C
  • Limb-girdle muscular dystrophy with gamma-sarcoglycan deficiency
  • Maghrebian myopathy
  • Muscular dystrophy, Duchenne-like
  • Severe childhood autosomal recessive muscular dystrophy, North African type
Who are the top Limb-Girdle Muscular Dystrophy Type 2C Local Doctors?
AF
Abdallah Fayssoil
Elite
Highly rated in
12
conditions

Ap Hp

Raymond Poincaré Hospital, 
Garches, FR 

Abdallah Fayssoil practices in Garches, France. Fayssoil is rated as an Elite expert by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Limb-Girdle Muscular Dystrophy Type 2C, Delta-Sarcoglycanopathy, Becker Muscular Dystrophy, and Duchenne Muscular Dystrophy.

KM
Dr. Katherine D. Mathews
Neurology | Pediatrics
Distinguished
Highly rated in
34
conditions
Neurology
Pediatrics

University of Iowa Health Care

State University Of Iowa

200 Hawkins Dr, 
Iowa City, IA 

Katherine Mathews is a Neurologist and a Pediatrics expert in Iowa City, Iowa. Mathews has been practicing medicine for over 42 years and is rated as a Distinguished expert by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. She is also highly rated in 34 other conditions, according to our data. Her top areas of expertise are Limb-Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2C, Limb-Girdle Muscular Dystrophy Type 1B, and Limb-Girdle Muscular Dystrophy Type 2A. Mathews is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
CW
Dr. Charles H. Whitaker
Neurology
Distinguished
Highly rated in
98
conditions
Neurology

Hospital For Special Care

80 Seymour St, 
Hartford, CT 

Charles Whitaker is a Neurologist in Hartford, Connecticut. Whitaker has been practicing medicine for over 32 years and is rated as a Distinguished expert by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. He is also highly rated in 98 other conditions, according to our data. His top areas of expertise are Limb-Girdle Muscular Dystrophy Type 2A, Limb-Girdle Muscular Dystrophy Type 2C, Limb-Girdle Muscular Dystrophy Type 1A, and Limb-Girdle Muscular Dystrophy Type 2I.

View All Doctors
What are the latest Limb-Girdle Muscular Dystrophy Type 2C Clinical Trials?
Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), and Type 2C (LGMD2C/R5)
Enrollment Status: Recruiting
Publish Date: January 11, 2023

Summary: This study will follow participants who are screened and confirmed with a genetic diagnosis of Limb-girdle muscular dystrophy type 2E (LGMD2E/R4), Limb-girdle muscular dystrophy type 2D (LGMD2D/R3), or Limb-girdle muscular dystrophy type 2C (LGMD2C/R5). These enrolled participants will be followed to evaluate mobility and pulmonary function for up to 3 years after enrollment. Additional participan...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Limb-Girdle Muscular Dystrophy Type 2C?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.